Therapeutic options in the polycystic ovary syndrome.

about

A subpathway-based method of drug reposition for polycystic ovary syndrome.Insulin resistance and the long-term consequences of polycystic ovary syndrome.Hepatotoxicity during low-dose flutamide treatment for hirsutism.

P2860

Q36742634-D7602F6B-9142-468F-8B63-E26A83EE1F98 Q37833622-F235A67A-EACF-401A-A7F5-8EC544BF496C Q43244963-D51E05A0-2D9E-4756-A6F3-C1DEA461CE1A

P2860

Therapeutic options in the polycystic ovary syndrome.

Item

http://www.wikidata.org/entity/Q36799800

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

Therapeutic options in the polycystic ovary syndrome.

@ast

Therapeutic options in the polycystic ovary syndrome.

@en

type

Item

label

Therapeutic options in the polycystic ovary syndrome.

@ast

Therapeutic options in the polycystic ovary syndrome.

@en

prefLabel

Therapeutic options in the polycystic ovary syndrome.

@ast

Therapeutic options in the polycystic ovary syndrome.

@en

P1476

Therapeutic options in the polycystic ovary syndrome.

@en

P2093

Bhathena RK

http://www.w3.org/2001/XMLSchema#string

P2860

Metformin in polycystic ovary syndrome: systematic review and meta-analysis

Efficacy of the combination ethinyl oestradiol and cyproterone acetate on endocrine, clinical and ultrasonographic profile in polycystic ovarian syndrome.

Comparison of Diane 35 and Diane 35 plus finasteride in the treatment of hirsutism.

Low-dose FSH therapy for anovulatory infertility associated with polycystic ovary syndrome: rationale, results, reflections and refinements.

Polycystic ovary syndrome: a risk factor for cardiovascular disease?

Hyperinsulinemia in polycystic ovary syndrome correlates with increased cardiovascular risk independent of obesity.

Percutaneous absorption and pharmacokinetics of eflornithine HCl 13.9% cream in women with unwanted facial hair.

The long term health consequences of polycystic ovary syndrome.

Clinical assessment of body hair growth in women.

Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS).

P304

123-129

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/01443610601113797

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2007-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17454455

http://www.w3.org/2001/XMLSchema#string

P921

polycystic ovary syndrome

Therapeutic options in the polycystic ovary syndrome.

about

P2860

P2860

Therapeutic options in the polycystic ovary syndrome.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921